Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David A. Socks currently holds 17,500 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Socks has been a net seller of CADX stock. They have purchased $0 and sold $19.3M worth of shares.
David A. Socks's most recent insider trade was on May 23, 2024, when they sold 17,500 shares at $0.00 per share.
David A. Socks serves as Executive at CADENCE PHARMACEUTICALS INC (CADX). They have executed 79 insider transactions totaling $19.3M over their tenure at the company.
David A. Socks holds the position of Executive at CADENCE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
David A. Socks has shown a selling trading pattern, with $0 in total purchases and $19.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David A. Socks was on Mar 11, 2021, when they sold $2.0M worth of PHAT shares. This transaction involved 41,698 shares at $47.18 per share.
David A. Socks currently owns 17,500 shares of CADENCE PHARMACEUTICALS INC (CADX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David A. Socks's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David A. Socks has 79 Form 4 filings on record as an insider at CADENCE PHARMACEUTICALS INC.
Set alerts for David A. Socks and 40,000+ other insiders.